Annual report pursuant to Section 13 and 15(d)

Fair Value Measurements - Contingent Value Right and Common Stock Warrant Valuation (Detail)

v3.24.1
Fair Value Measurements - Contingent Value Right and Common Stock Warrant Valuation (Detail)
$ / shares in Units, $ in Thousands
12 Months Ended
Jun. 16, 2023
USD ($)
item
$ / shares
shares
Dec. 31, 2023
USD ($)
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Change in valuation of contingent value right   $ (2,457)
Issuance of warrants   2,316
CVR Agreement    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Number of components | item 2  
Remaining value convertible $ 3,000  
Expected value of conversion right if rights are not converted into shares 0  
Fair value of conversion right 3,300 1,500
Fair value of contingent value liability 1,900 $ 1,200
Change in valuation of conversion right 1,800  
Change in valuation of contingent value right $ 700  
Warrants to purchase shares of common stock | shares 340,222  
Exercise price of warrant | $ / shares $ 5.8785  
Warrants term 10 years  
Issuance of warrants $ 2,300